Ticker Launch

SPAC · Deal announced · RIBB

Ribbon Acquisition Corp.

Business combination with DRC Medicine Ltd

Ribbon Acquisition Corp. (RIBB) is a blank-check company (SPAC) that raised $50M in its initial public offering on Jan 16, 2025. It agreed to combine with DRC Medicine Ltd, announced on Jul 1, 2025. The deal has not closed yet. Sichenzia Ross Ference Carmel advised the SPAC and Loeb & Loeb advised the underwriters on the IPO.

DRC Medicine Ltd, founded in 2007 and headquartered in Japan, is a healthcare and biotechnology company that researches and develops medical technologies. It is known for its Hydro Silver Titanium technology, used in masks and towels and now being advanced toward certification as a therapeutic mask for seasonal allergic rhinitis.

Status
Deal announced
Ticker
RIBB
IPO date
Jan 16, 2025
IPO size
$50M
Target
DRC Medicine Ltd
Target sector
Healthcare
Announced
Jul 1, 2025
Combined company
DRC Medicine Inc.
SPAC counsel (IPO)
Sichenzia Ross Ference Carmel and Ogier
Underwriters' counsel (IPO)
Loeb & Loeb

More on this SPAC for subscribers

Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.

Then $99/month or $999/year. Cancel anytime.

Filings

Other pending SPAC mergers